Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

H He Chen (Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute) S Sixing Liu S Shuai Gao (Women and Children’s Hospital of Qingdao University, Qingdao, China.) H Hangyu Shi Y Yan Yan Y Yixing Xu J Jiufei Fang W Weiming Wang (Ruijin Hospital, Shanghai Jiaotong University, Shanghai) H Huan Chen Z Zhishun Liu